Research map: Skeletal muscle radiodensity as an automated survival predictor in men with metastatic castration-resistant prostate cancer undergoing PSMA-targeted radioligand therapy

Back to the article

Papers in this map

  1. Sarcopenia · Alfonso José Cruz-Jentoft · 2019 · 3856 citations · Cited by this paper
  2. Real-world evaluation of [177Lu]Lu-PSMA-617 RLT in post-taxane mCRPC: feasibility and safety of individualized treatment in a challenging cohort · 2026 · Related
  3. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer · Oliver A. Sartor · 2021 · 2844 citations · Cited by this paper
  4. Whole-body TSPO-PET reveals stage-dependent disruption of systemic immune organ interactions in glioblastoma · 2026 · Related
  5. Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index · Lisa Warsinger Martin · 2013 · 2744 citations · Cited by this paper
  6. Evaluation of treatment efficacy of the 161Tb- and 177Lu-Labeled GRPR antagonists AMTG and RM2 in a mouse model of prostate cancer · 2026 · Related
  7. Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment · Carla Marques Maia Prado · 2009 · 1131 citations · Cited by this paper
  8. From image reconstruction to clinical prognosis: A comprehensive analysis of centiloid-based amyloid PET assessment · 2026 · Related
  9. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review · Shlomit Strulov Shachar · 2016 · 1131 citations · Cited by this paper
  10. [18F]FDG PET during immunotherapy: mind the gap between evidence, imaging guidelines, and oncology practice · 2026 · Related
  11. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions · Ali Afshar‐Oromieh · 2015 · 436 citations · Cited by this paper
  12. CSF proteomic pathway alterations and caudate dopamine transporter deficits predict cognitive vulnerability in early Parkinson’s disease · 2026 · Related
  13. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy · Vickie Elaine Baracos · 2018 · 371 citations · Cited by this paper
  14. In vivo multimodal PET/MRI imaging and plasma biomarkers implicate glymphatic dysfunction linking neuroinflammation to tau pathology in the early Alzheimer’s disease continuum · 2026 · Related
  15. Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma · Michael S. Sabel · 2011 · 271 citations · Cited by this paper
  16. Prospective comparison of [68Ga]Ga-FAPI-04 PET/MRI, [18F]FDG PET/CT, and contrast-enhanced MRI for predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer · 2026 · Related
  17. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies · Sami Antoun · 2013 · 223 citations · Cited by this paper
  18. 68Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data · 2026 · Related
  19. [177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer · Clemens Kratochwil · 2015 · 202 citations · Cited by this paper
  20. Personalized metabolic connectome analysis reveals glucose heterogeneity in ischemic cerebrovascular disease · 2026 · Related
  21. The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma · Louise E. Daly · 2017 · 187 citations · Cited by this paper
  22. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer · Bjørg Sjøblom · 2016 · 148 citations · Cited by this paper
  23. Muscle radiodensity and mortality in patients with colorectal cancer · Candyce H. Kroenke · 2018 · 141 citations · Cited by this paper
  24. Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177 Lu-PSMA-617 Radioligand Therapy · Robert Seifert · 2020 · 141 citations · Cited by this paper
  25. Semiautomatically Quantified Tumor Volume Using 68 Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer · Robert Seifert · 2020 · 134 citations · Cited by this paper
  26. Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study · Madeleine J. Karpinski · 2024 · 86 citations · Cited by this paper
  27. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis · Alina Vrieling · 2016 · 72 citations · Cited by this paper
  28. Augmented Radiologist Workflow Improves Report Value and Saves Time: A Potential Model for Implementation of Artificial Intelligence · Huy M. · 2019 · 72 citations · Cited by this paper
  29. A noise-optimized virtual monoenergetic reconstruction algorithm improves the diagnostic accuracy of late hepatic arterial phase dual-energy CT for the detection of hypervascular liver lesions · Carlo Nicola De Cecco · 2018 · 71 citations · Cited by this paper
  30. End-to-end automated body composition analyses with integrated quality control for opportunistic assessment of sarcopenia in CT · Sebastian Nowak · 2021 · 64 citations · Cited by this paper
  31. Fully Automated Segmentation of Connective Tissue Compartments for CT-Based Body Composition Analysis · Sebastian Nowak · 2020 · 61 citations · Cited by this paper
  32. Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy · Ayako Ohtaka · 2018 · 60 citations · Cited by this paper
  33. Body composition and cancer survival: a narrative review · Patrick T. Bradshaw · 2023 · 57 citations · Cited by this paper
  34. Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic review · Kanchi Patell · 2023 · 56 citations · Cited by this paper
  35. Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement · Julian Alexander Luetkens · 2020 · 38 citations · Cited by this paper
  36. Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area · Anton Faron · 2020 · 35 citations · Cited by this paper
  37. Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation · Yansheng Kan · 2020 · 28 citations · Cited by this paper
  38. Deep learning–based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment · Sebastian Nowak · 2023 · 26 citations · Cited by this paper
  39. Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer · Ji Hyun Lee · 2021 · 25 citations · Cited by this paper

Source: OpenAlex (CC0)